Search

everythinglearnresearchcommunity

for

Search:↓

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

KY19382 helps regrow hair and create new hair follicles.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Early diagnosis, genetic testing, and personalized care are essential for managing tuberous sclerosis.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Baricitinib may not always prevent relapse in alopecia areata.

Baricitinib effectively and safely improves hair growth in patients with severe alopecia areata.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Hedgehog pathway inhibitors could be effective in treating melanoma.